Stokes Family Office’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
|
|||||
|
2025
Q1 | $586K | Sell |
|
|||||
|
2024
Q4 | $729K | Buy |
|
|||||
|
2024
Q3 | $982K | Hold |
|
|||||
|
2024
Q2 | $1.18M | Buy |
|
|||||
|
2024
Q1 | $1.02M | Hold |
|
|||||
|
2023
Q4 | $825K | Sell |
|
|||||
|
2023
Q3 | $884K | Sell |
|
|||||
|
2023
Q2 | $798K | Buy |
|
|||||
|
2023
Q1 | $749K | Sell |
|
|||||
|
2022
Q4 | $689K | Buy |
|
|||||
|
2022
Q3 | $491K | Sell |
|
|||||
|
2022
Q2 | $565K | Buy |
|
|||||
|
2022
Q1 | $546K | Buy |
|
|||||
|
2021
Q4 | $530K | Buy |
|
|||||
|
2021
Q3 | $452K | Buy |
|
|||||
|
2021
Q2 | $384K | Buy |
|
|||||
|
2021
Q1 | $291K | Buy |
|
|||||
|
2020
Q4 | $270K | Hold |
|
|||||
|
2020
Q3 | $269K | Buy |
|
|||||
|
2020
Q2 | $229K | Sell |
|
|||||
|
2020
Q1 | $214K | Hold |
|
|||||
|
2019
Q4 | $205K | Buy |
|